Gapping up
In reaction to strong earnings/guidance: NEO +11.8%,
SC +10.3%,
CUDA +10%,
STM +9.6%,
WNC +9.3%,
FTNT +8.1%,
SONS +7.4%,
EURN +6.9%,
SONS +6.7%,
BSX +6.4%,
ACCO +5.1%,
HUBG +5%,
TSS +4.9%,
EXK +4.5%,
MKTO +4.4%,
CREE +3.7%,
BLDP +3.5%,
STO +3.3%,
MDLZ +3.3%,
NUVA +3%,
TEX +2.9%,
LEA +2.5%,
FBRC +2.5%,
VNTV +2.2%, (promotes Stephanie Ferris to CFO),
PNRA +2.1%,
FE +1.9%,
WEX +1.9%,
CRH +1.9%,
WEX +1.9%,
SXC +1.7%,
CMCSA +1.7%,
SXC +1.7%,
TRU +1.6%,
SXCP +1.6%,
TOT +1.6%,
HLS +1.5%,
SIX +1.4%,
SKT +1.3%,
EW +1.3%,
EBAY +1.3%,
DPS +1.3%,
AOS +1.2%,
UTX +1.1%,
IP +1.1%,
WCIC +1%,
SO +1%,
UMC +0.9%,
UTX +0.9%,
SAN +0.8%,
MRCY +0.7%,
NOC +0.7%,
BGCP +0.7%
M&A news: DWA +17.8% (Comcast (CMCSA) is in discussions to purchase DWA for $3 bln, according to WSJ),
EXAM +4.9% (to be acquired by Leonard Green & Partners for $35.05/share)
Select oil/gas related names showing strength: BCEI +7.5%,
WLL +4.9%,
SDRL +4.5%,
DNR +3.2%,
PTR +2.9%,
MRO +2.4%,
SDLP +2.4%,
Other news: OASM +12.1% (reports positive overall survival results from Phase III study of Paclical/Apealea; marketing approval in US anticipated for the end of 2016/2017),
CUDA +10.5% (in sympathy with FTNT),
MEMP +6% (declared Q1 cash distribution of $0.03 per unit, represents $0.07 per unit reduction from MEMP's fourth quarter 2015 distribution ),
EQC +5.1% (light volume; confirms is under contract to sell its leasehold interest in Hoboken property with gross sale price of $235 mln),
CYTX +3.8% (announces an independent DMC has reviewed safety data from the initial 40 patients and recommended that its Phase 3 STAR trial continue as planned),
ACUR +3.6% (has been issued U.S. Patent No. 9,320,796 by the USPTO pertaining to its Limitx Technology platform),
OPB +3.5% ( to join S&P SmallCap 600),
VSAT +1.3% (to join S&P MidCap 400),
AYI +1% (to join the S&P 500)
Analyst comments: NOV +2.7% (upgraded to Overweight from Underweight at Morgan Stanley),
KORS +1.7% (upgraded to Overweight from Neutral at Piper Jaffray)